Inhibition of HIV infection by the cytokine midkine

C Callebaut1, S Nisole, J P Briand

  • 1Unité de Virologie et Immunologie Cellulaire, URA 1930 CNRS, Institut Pasteur, 28 rue du Dr. Roux, 75724 Paris Cedex 15, France.

Virology
|March 30, 2001
PubMed

Insights

The growth factor midkine (MK) inhibits HIV-1 infection by binding to cell surface components. This cytokine’s expression increases with immune stimulation, suggesting a role in HIV pathogenesis.

Area of Science:

  • Immunology
  • Virology
  • Molecular Biology

Background:

  • Midkine (MK) binds heparan sulfate and nucleolin, cell surface components involved in HIV-1 attachment.
  • HIV-1 entry into cells is a critical step in viral infection.

Purpose of the Study:

  • To investigate the potential of midkine (MK) as an inhibitor of HIV-1 infection.
  • To explore the role of MK in lymphocyte responses to HIV-1.

Main Methods:

  • Inhibition assays using synthetic and recombinant MK against HIV-1 isolates.
  • Cell surface binding studies with labeled MK and anti-HIV pseudopeptide HB-19.
  • Analysis of MK mRNA expression in lymphocytes stimulated with cytokines and mitogens.
  • Colocalization studies of MK and nucleolin on lymphocyte cell surfaces.
  • Assessment of HIV infection inhibition in MK-producing CD4(+) and CD4(-) cell clones.

Main Results:

  • MK demonstrated dose-dependent inhibition of T-lymphocyte- and macrophage-tropic HIV-1 infection.
  • MK binding to cells was blocked by excess MK or HB-19, indicating a shared binding mechanism with nucleolin.
  • MK mRNA expression was constitutive in lymphocytes and increased upon stimulation with IL-2, IFN-gamma, PHA, or anti-CD3/CD28 antibodies.
  • MK was detected at the cell surface of lymphocytes, colocalizing with nucleolin.
  • MK inhibited HIV infection in both autocrine and paracrine manners in cell cultures.

Conclusions:

  • Midkine (MK) possesses potent anti-HIV-1 activity by interfering with viral entry.
  • Enhanced MK expression in lymphocytes upon immune activation suggests a regulatory role in HIV infection.
  • MK is a cytokine implicated in the pathogenesis of HIV infection.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...